This is in contrast with the recent finding of Du et al., who found that HOXA9 hypermethylation was not significantly associated with advanced NSCLC stage when comparing patients in stage IA to the rest of the cohort [26]. This evidence concerns the gene HOXA9 and non-small cell lung carcinoma.